106 related articles for article (PubMed ID: 30909959)
1. Correction to: De novo and inherited TCF20 pathogenic variants are associated with intellectual disability, dysmorphic features, hypotonia, and neurological impairments with similarities to Smith-Magenis syndrome.
Vetrini F; McKee S; Rosenfeld JA; Suri M; Lewis AM; Nugent KM; Roeder E; Littlejohn RO; Holder S; Zhu W; Alaimo JT; Graham B; Harris JM; Gibson JB; Pastore M; McBride KL; Komara M; Al-Gazali L; Al Shamsi A; Fanning EA; Wierenga KJ; Scott DA; Ben-Neriah Z; Meiner V; Cassuto H; Elpeleg O; Lloyd Holder J; Burrage LC; Seaver LH; Van Maldergem L; Mahida S; Soul JS; Marlatt M; Matyakhina L; Vogt J; Gold JA; Park SM; Varghese V; Lampe AK; Kumar A; Lees M; Holder-Espinasse M; McConnell V; Bernhard B; Blair E; Harrison V; ; Muzny DM; Gibbs RA; Elsea SH; Posey JE; Bi W; Lalani S; Xia F; Yang Y; Eng CM; Lupski JR; Liu P
Genome Med; 2019 Mar; 11(1):16. PubMed ID: 30909959
[TBL] [Abstract][Full Text] [Related]
2. De novo and inherited TCF20 pathogenic variants are associated with intellectual disability, dysmorphic features, hypotonia, and neurological impairments with similarities to Smith-Magenis syndrome.
Vetrini F; McKee S; Rosenfeld JA; Suri M; Lewis AM; Nugent KM; Roeder E; Littlejohn RO; Holder S; Zhu W; Alaimo JT; Graham B; Harris JM; Gibson JB; Pastore M; McBride KL; Komara M; Al-Gazali L; Al Shamsi A; Fanning EA; Wierenga KJ; Scott DA; Ben-Neriah Z; Meiner V; Cassuto H; Elpeleg O; Holder JL; Burrage LC; Seaver LH; Van Maldergem L; Mahida S; Soul JS; Marlatt M; Matyakhina L; Vogt J; Gold JA; Park SM; Varghese V; Lampe AK; Kumar A; Lees M; Holder-Espinasse M; McConnell V; Bernhard B; Blair E; Harrison V; ; Muzny DM; Gibbs RA; Elsea SH; Posey JE; Bi W; Lalani S; Xia F; Yang Y; Eng CM; Lupski JR; Liu P
Genome Med; 2019 Feb; 11(1):12. PubMed ID: 30819258
[TBL] [Abstract][Full Text] [Related]
3. De novo nonsense and frameshift variants of TCF20 in individuals with intellectual disability and postnatal overgrowth.
Schäfgen J; Cremer K; Becker J; Wieland T; Zink AM; Kim S; Windheuser IC; Kreiß M; Aretz S; Strom TM; Wieczorek D; Engels H
Eur J Hum Genet; 2016 Dec; 24(12):1739-1745. PubMed ID: 27436265
[TBL] [Abstract][Full Text] [Related]
4. Exome analysis of Smith-Magenis-like syndrome cohort identifies de novo likely pathogenic variants.
Berger SI; Ciccone C; Simon KL; Malicdan MC; Vilboux T; Billington C; Fischer R; Introne WJ; Gropman A; Blancato JK; Mullikin JC; ; Gahl WA; Huizing M; Smith ACM
Hum Genet; 2017 Apr; 136(4):409-420. PubMed ID: 28213671
[TBL] [Abstract][Full Text] [Related]
5. [Diagnostic difficulties in Smith-Magenis Syndrome (SMS) on the basis of own experience and literature data].
Stembalska A; Jakubiak A; Śmigiel R
Med Wieku Rozwoj; 2012; 16(2):138-43. PubMed ID: 22971658
[TBL] [Abstract][Full Text] [Related]
6. Neurologic and developmental features of the Smith-Magenis syndrome (del 17p11.2).
Gropman AL; Duncan WC; Smith AC
Pediatr Neurol; 2006 May; 34(5):337-50. PubMed ID: 16647992
[TBL] [Abstract][Full Text] [Related]
7. A
Chen Y; Liu KY; Yang ZL; Li XH; Xu R; Zhou H
Front Pediatr; 2020; 8():303. PubMed ID: 32714884
[No Abstract] [Full Text] [Related]
8. Molecular basis for phenotypic similarity of genetic disorders.
Pounraja VK; Girirajan S
Genome Med; 2019 Apr; 11(1):24. PubMed ID: 31014384
[TBL] [Abstract][Full Text] [Related]
9. Individuals with Smith-Magenis syndrome display profound neurodevelopmental behavioral deficiencies and exhibit food-related behaviors equivalent to Prader-Willi syndrome.
Alaimo JT; Barton LV; Mullegama SV; Wills RD; Foster RH; Elsea SH
Res Dev Disabil; 2015 Dec; 47():27-38. PubMed ID: 26323055
[TBL] [Abstract][Full Text] [Related]
10. Intellectual Disability in Two Brothers Caused by De Novo Novel Unbalanced Translocation (13;18) (q34,q23) and De Novo Microdeletion 6q25 Syndrome.
Alhashem AM; Almohaid MS; Alanazi L; Alhabardi H
Cureus; 2020 Jan; 12(1):e6778. PubMed ID: 32010537
[TBL] [Abstract][Full Text] [Related]
11. Confirmation of chromosomal microarray as a first-tier clinical diagnostic test for individuals with developmental delay, intellectual disability, autism spectrum disorders and dysmorphic features.
Battaglia A; Doccini V; Bernardini L; Novelli A; Loddo S; Capalbo A; Filippi T; Carey JC
Eur J Paediatr Neurol; 2013 Nov; 17(6):589-99. PubMed ID: 23711909
[TBL] [Abstract][Full Text] [Related]
12. A previously unrecognized 22q13.2 microdeletion syndrome that encompasses TCF20 and TNFRSF13C.
Upadia J; Gonzales PR; Atkinson TP; Schroeder HW; Robin NH; Rudy NL; Mikhail FM
Am J Med Genet A; 2018 Dec; 176(12):2791-2797. PubMed ID: 30216695
[TBL] [Abstract][Full Text] [Related]
13. De novo pathogenic variants in CHAMP1 are associated with global developmental delay, intellectual disability, and dysmorphic facial features.
Tanaka AJ; Cho MT; Retterer K; Jones JR; Nowak C; Douglas J; Jiang YH; McConkie-Rosell A; Schaefer GB; Kaylor J; Rahman OA; Telegrafi A; Friedman B; Douglas G; Monaghan KG; Chung WK
Cold Spring Harb Mol Case Stud; 2016 Jan; 2(1):a000661. PubMed ID: 27148580
[TBL] [Abstract][Full Text] [Related]
14. Expanding the Spectrum of BAF-Related Disorders: De Novo Variants in SMARCC2 Cause a Syndrome with Intellectual Disability and Developmental Delay.
Machol K; Rousseau J; Ehresmann S; Garcia T; Nguyen TTM; Spillmann RC; Sullivan JA; Shashi V; Jiang YH; Stong N; Fiala E; Willing M; Pfundt R; Kleefstra T; Cho MT; McLaughlin H; Rosello Piera M; Orellana C; Martínez F; Caro-Llopis A; Monfort S; Roscioli T; Nixon CY; Buckley MF; Turner A; Jones WD; van Hasselt PM; Hofstede FC; van Gassen KLI; Brooks AS; van Slegtenhorst MA; Lachlan K; Sebastian J; Madan-Khetarpal S; Sonal D; Sakkubai N; Thevenon J; Faivre L; Maurel A; Petrovski S; Krantz ID; Tarpinian JM; Rosenfeld JA; Lee BH; ; Campeau PM
Am J Hum Genet; 2019 Jan; 104(1):164-178. PubMed ID: 30580808
[TBL] [Abstract][Full Text] [Related]
15. De novo missense variants in HECW2 are associated with neurodevelopmental delay and hypotonia.
Berko ER; Cho MT; Eng C; Shao Y; Sweetser DA; Waxler J; Robin NH; Brewer F; Donkervoort S; Mohassel P; Bönnemann CG; Bialer M; Moore C; Wolfe LA; Tifft CJ; Shen Y; Retterer K; Millan F; Chung WK
J Med Genet; 2017 Feb; 54(2):84-86. PubMed ID: 27389779
[TBL] [Abstract][Full Text] [Related]
16. Abnormal brain magnetic resonance imaging in two patients with Smith-Magenis syndrome.
Maya I; Vinkler C; Konen O; Kornreich L; Steinberg T; Yeshaya J; Latarowski V; Shohat M; Lev D; Baris HN
Am J Med Genet A; 2014 Aug; 164A(8):1940-6. PubMed ID: 24788350
[TBL] [Abstract][Full Text] [Related]
17. Smith-Magenis Syndrome: Face Speaks.
Gupta R; Gupta N; Nampoothiri S; Mandal K; Kishore Y; Sharma P; Kabra M; Phadke SR
Indian J Pediatr; 2016 Jun; 83(6):589-93. PubMed ID: 26676648
[TBL] [Abstract][Full Text] [Related]
18. Smith-Magenis Syndrome and Social Security Administration's Compassionate Allowances Initiative: An Evaluative Review of the Literature.
Burke SL; Maramaldi P
Intellect Dev Disabil; 2016 Aug; 54(4):273-84. PubMed ID: 27494126
[TBL] [Abstract][Full Text] [Related]
19. New developments in Smith-Magenis syndrome (del 17p11.2).
Gropman AL; Elsea S; Duncan WC; Smith AC
Curr Opin Neurol; 2007 Apr; 20(2):125-34. PubMed ID: 17351481
[TBL] [Abstract][Full Text] [Related]
20. [Genetic diagnosis of a child with Smith-Magenis syndrome].
Gao Y; Wu D; Huo X; Zhang M; Hou Q; Wang H; Liao S
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2019 Jul; 36(7):724-726. PubMed ID: 31302921
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
